Pisa syndrome is a disabling, medication-resistant, postural abnormality that may affect 7-10% of patients with Parkinson's disease. In this study, we sought to assess the efficacy of botulinum toxin injections in Parkinson's disease-associated Pisa syndrome using a Magnetic Resonance Imaging-, Ultrasonography-, and Electromyography-guided combined approach.
Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study
Artusi, Carlo Alberto;Bortolani, Sara;Merola, Aristide;Zibetti, Maurizio;Busso, Marco;De Mercanti, Stefania;Arnoffi, Paolo;Veltri, Andrea;Barbero, Pierangelo;Lopiano, Leonardo
Last
2019-01-01
Abstract
Pisa syndrome is a disabling, medication-resistant, postural abnormality that may affect 7-10% of patients with Parkinson's disease. In this study, we sought to assess the efficacy of botulinum toxin injections in Parkinson's disease-associated Pisa syndrome using a Magnetic Resonance Imaging-, Ultrasonography-, and Electromyography-guided combined approach.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Artusi.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
388.37 kB
Formato
Adobe PDF
|
388.37 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
